Pharm Tech Agenda 2015.08.12

From IHE Wiki
Jump to: navigation, search

Meeting details

Wednesday, 12 August 2015, 15:00 CET/CEST

WebEx details:

https://phastinternational.webex.com/phastinternational-en/j.php?MTID=m27280cdd93cb8eab4be37a7f0cc1f3d2

Meeting number: 954 257 460

JOIN BY PHONE

+33 17091 8646 France toll

0800-9-19312 France toll free

Call-in Numbers: Global Call-in numbers

Access code: 954 257 460

Agenda

  • Recap from last webex
  • Relevant updates from FHIR
  • Continuing the discussion - Goal is to reach a point where we can start to define actors and start checking the FHIR resources and determine if it is consistent with HMW / CMPD.


Recap from last webex:

Materials on the FTP site

  • We agreed with a few aspects in the model outlined in the PPT:
  • Medication "Ordering" is a set of activities that we may aggregate for consistency (We may use a single type of resource for these activities). It includes:
  • Planning (e.g. "draft" prescription),
  • Prescribing
  • ... or other ordering that is the same as prescribing? Like a nurse's "prescription"?
  • Order review?
  • "Order Review" may be a better candidate than "Pharmaceutical Advice".
  • "Medication Dispense" may include several activities. At this moment we are not making a distinction.
  • Administration actor may be best called Administration Performer
  • Out of the discussion were:
* "Prescription Management" - the mechanisms to enable that a prescription can be understood as "valid for dispense" etc. are at this moment left out of the discussion. Maybe in or out of scope - that is not decided yet.
  • ADE Reporting and post-administration events.
  • Medication Statements by a patient
  • Medication Lists
  • Medication Catalog - how different actors are prepared to share names and attributes of medications.
  • Supply aspects other than the dispensing


Relevant updates on FHIR:

  • Medication Prescription is being renamed to MedicationOrder
  • This is compatible with the suggestion to use one single resource for different orders.
  • Prescription statuses are beign discussed - Prescription order status changes like "draft" or "entered in error", and NOT overall workflow status like "completed".
  • Identification of medication has been reviewed.


Next

Questions:

  • Scope: This being for FHIR, do we want to stick to a scope (e.g. in-country) or prepare for cross-country?
  • Decision: The profile should be prepared for the scope of CMPD and HMW; we shall not focus on the specifics to make it e.g. cross-country (e.g. translation or conversion of medication codes/names for cross-country dispense, etc.).